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In the healthy intestinal mucosa, homeostasis
between the immune system and commensal micro-
flora prevents detrimental inflammatory responses.
Infection with acute enteropathogens such asSalmo-
nella enterica serovar Typhimurium disturbs this
homeostasis and triggers inflammation, but the
underlying mechanisms are poorly understood. We
found that bacterial delivery or ectopic expression
of the S. Typhimurium type III effector protein SopE,
a known activator of host cellular Rho GTPases, led
to proinflammatory caspase-1 activation and conse-
quent maturation and secretion of the cytokine IL-1b.
In vivo, SopE triggered mucosal inflammation in wild-
type but not caspase-1/, IL-1R/, or IL-18/
mice. Bone marrow chimeras indicated that cas-
pase-1 was more important in stromal cells, most
likely enterocytes, than in bone marrow-derived cells.
SopE-mediated caspase-1 activation in vitro was
mediated by cellular Rho GTPases Rac-1 and
Cdc42. These findings implicate SopE-driven Rho
GTPase-mediated caspase-1 activation in stromal
cells as a mechanism eliciting mucosal inflammation
during S. Typhimurium infection.
INTRODUCTION
The intestinal mucosa is exposed to numerous microbes. In the
absence of pathogens, the healthy intestine is characterized by
homeostasis of the immune system with the commensal micro-
flora. In the event of an acute infection, this homeostasis is
disturbed. Innate, proinflammatory responses are triggered to
limit infection and initiate adaptive immunity. The molecular
mechanisms initiating these mucosal responses against patho-
gens, but not against harmless commensals, are poorly under-
stood (Vance et al., 2009). We have used Salmonella enterica
subspecies I serovar Typhimurium (termedS. Typhimurium here-
after) to study these mechanisms.Cell HS. Typhimurium is a Gram-negative enteropathogen causing
diarrheal disease. The pathogen invades the intestinal mucosa
and triggers pronounced inflammation. We have studied the strat-
egies used by S. Typhimurium for eliciting mucosal inflammation.
S. Typhimurium triggers gut inflammation by means of two
type III secretion systems, T1 and T2 (Figure 1A). These are
molecular syringes injecting cocktails of bacterial ‘‘effector
proteins’’ into host cells to provoke specific responses (Schlum-
berger and Hardt, 2006). Triggering inflammation relies on the
presence of injected T1 and T2 effector proteins. T1 and T2
can mediate inflammation independently of each other, by the
‘‘classical’’ (T1-dependent) or the ‘‘alternative’’ (T2-dependent)
pathway (Hapfelmeier and Hardt, 2005; Hapfelmeier et al.,
2008) (Figure 1A). Here we have focused on the T1-mediated,
classical pathway of S. Typhimurium enterocolitis.
In the gut lumen, S. Typhimurium expresses T1 (Ackermann
et al., 2008). Injection of T1 effector proteins into target cells of
the gut mucosa promotes pathogen entry into epithelial cells (en-
terocytes). Among the T1 effector proteins, SopE, SipA, SopE2,
and SopB are best characterized. In a mouse model of mucosal
inflammation, they elicit a strong inflammatory response within
8 hr (Barthel et al., 2003; Hapfelmeier et al., 2004). Strains that
express SipA (but lacking SopE, SopE2, and SopB) or SopE
(but lacking SipA, SopB, and SopE2) induce mucosal inflamma-
tion, whereas those expressing SopE2 or SopB in the absence of
SipA and SopE do not (Hapfelmeier et al., 2004; Zhang et al.,
2002b). Therefore, SipA and SopE are of key importance for
eliciting gut inflammation (Hapfelmeier et al., 2004; Zhang
et al., 2002a, 2002b) (Figure 1A).
SipA and SopE mediate invasion into epithelial cells. SopE is a
guanine nucleotide exchange factor that activates Rho GTPases,
in particular Rac1 and Cdc42 (Hardt et al., 1998). SipA binds actin
and promotes actin polymerization and bundling (McGhie et al.,
2004; Zhou et al., 1999). However, the proinflammatory mecha-
nisms elicited by SipA and SopE in vivo are poorly understood.
Caspase-1 is a converging point of several signal pathways
controlling innate immune defenses (Ishii et al., 2008). Stimuli like
bacterial LPS, RNA, flagellin, or toxin-inflicted membrane damage
can initiate the assembly of ‘‘inflammasomes,’’ comprising cas-
pase-1 and NOD-LRR family proteins (Martinon and Tschopp,
2004). They activate caspase-1, which leads to processing andost & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc. 125
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kines IL-1b and IL-18 (Keller et al., 2008; Kostura et al., 1989). Cas-
pase-1, IL-1b, and IL-18 are essential for the defense against
a variety of pathogens including systemic S. Typhimurium infec-
tions (Lara-Tejero et al., 2006; Raupach et al., 2006). However,
the roleofcaspase-1 in the intestinalmucosahas remainedunclear.
Several bacterial type III effector proteins can inhibit caspase-
1 activation, thus dampening immune defenses (Galle et al.,
2007; Schotte et al., 2004; Sutterwala et al., 2007). For example,
Yersinia YopE interferes with caspase-1 activation by inactivat-
ing host Rho GTPases (Schotte et al., 2004). This suggested
that SopE, a potent Rho GTPase activator, might have the oppo-
site effect, i.e., Rho GTPase activation by SopE might activate
caspase-1 and thereby elicit mucosal inflammation in vivo. Given
Figure 1. SopE Is a Key Activator of Cas-
pase-1 and IL-1b Secretion In Vitro
(A) (Model) S. Typhimurium elicits enterocolitis via
a ‘‘classical’’ and an ‘‘alternative’’ pathway. (Left)
Classical pathway. S. Typhimurium manipulates
mucosal cells via T1 effector proteins. SopE acti-
vates Rho GTPases like Rac1 and Cdc42 (Hardt
et al., 1998). SipA manipulates F-actin (Higashide
et al., 2002; McGhie et al., 2004; Zhou et al.,
1999). It is unknown how SopE and SipA elicit
inflammation in vivo. (Right) Alternative pathway,
subverting dendritic cells for penetrating the
epithelium (Coombes et al., 2005; Hapfelmeier
and Hardt, 2005; Hapfelmeier et al., 2008).
(B–D) Key role of T1 and SopE in caspase-1 activa-
tion in HeLa cells. HeLa cells were infected for 30
min as indicated (moi = 125). Caspase-1 activation
was analyzed with FLICA.
(E) SopE activates caspase-1 in RAW264.7
macrophages. Cells were infected for 30 min as
indicated (moi = 50) and stained with FLICA and
PI. Data were from greater than or equal to three
assays (average + standard deviation).
(F) SopE-induced IL-1b secretion from RAW264.7
macrophages. Cells were infected for 30 min as
indicated, and mature IL-1b release was analyzed.
The assay was done in triplicate; average + stan-
dard deviation of a representative of two indepen-
dent experiments are shown.
this, we sought to analyze how SopE trig-
gers inflammation and whether caspase-
1 signaling is involved. We found that
SopE activates caspase-1, which trig-
gers the release of IL-1 and IL-18 and
results in inflammation in vivo. SopE acti-
vation of Rho GTPases is sufficient to
trigger caspase-1 activation in vitro. Our
findings explain how the S. Typhimurium
T1 effector SopE elicits gut inflammation.
RESULTS
SopE Is a Key Mediator of
Caspase-1 Activation In Vitro
First, we analyzed whether S. Typhimu-
rium activates caspase-1 in epithelial
HeLa cells in vitro using a FLICA (FAM-YVAD-FMK)-binding
assay for activated caspase-1 (Gurcel et al., 2006). Wild-type
S. Typhimurium activated caspase-1 (WT; Figure 1B). To deter-
mine the role of T1 and T2, we compared WT S. Typhimurium,
T1 (DinvG), T2 (sseD::aphT), and T1T2 (DinvG sseD::aphT;
see Table S1 available online). WT and T2 triggered caspase-
1 activation, while T1 and T1T2 did not (Figure 1B). Thus,
T1 is required for caspase-1 activation by S. Typhimurium in
HeLa cells, while T2 is dispensable.
Next, we analyzed the contribution of individual T1-effector
proteins to caspase-1 activation. We compared WT, S.TmSopE*
(injects SopE; lacks SipA, SopB, SopE2), S.TmSipA* (injects
SipA; lacks SopE, SopB, SopE2), S.TmSopE2* (injects SopE2;
lacks SipA, SopE, SopB), S.TmSopB* (injects SopB; lacks SipA,126 Cell Host & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc.
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Salmonella SopE Triggers Caspase-1/IL-1 In VivoSopE, SopE2), and S.TmD4* (lacks SipA, SopE, SopB, SopE2;
Table S1). Remarkably, S.TmSopE* activated caspase-1 as effi-
ciently as WT bacteria (Figure 1C). S.TmSipA*, S.TmSopB* and
S.TmSopE2* were significantly less efficient, and S.TmD4* did
not activate caspase-1. Equivalent results were obtained with
isogenic strains lacking a functional T2 virulence system (Table
S1; Figure 1D; e.g., compare S.TmSopE* with S.TmSopE). Further-
more, caspase-1 activation required the guanine nucleotide
exchange activity of SopE, as indicated by controls using a cata-
lytic site mutant (sopEG168V; Figure S1). Thus, SopE is the key T1
effector protein required for caspase-1 activation in HeLa cells.
Next, we analyzed macrophage-like RAW264.7 cells. We moni-
tored caspase-1 activation, the associated loss of membrane
integrity (propidium iodide staining, PI [Fink and Cookson,
2006]) typically observed in these cells, as well as IL-1b secretion
(Experimental Procedures). S.TmSopE* activated caspase-1 and
induced membrane permeabilization and mature IL-1b secretion
as efficiently as WT (Figures 1E and 1F). Caspase-1 activation
by S.TmSopB*, S.TmSopE2*, and S.TmSipA* was much less
pronounced and did not differ significantly from S.TmD4*
(Figure 1E). However, in contrast to our results with HeLa cells,
strain S.TmD4* induced low but detectable caspase-1 activation
and IL-1b release in RAW264.7 cells (Figures 1E and 1F; compare
S.TmD4* and noninfected controls). We assume that this residual
caspase-1 activation by S.TmD4* is attributable to T1-mediated
SipB or flagellin injection (Franchi et al., 2006; Hersh et al., 1999;
Miao et al., 2006). Caspase-1 activation in T1-infected
RAW264.7 cells did not differ from noninfected controls
(Figure 1E). In conclusion, the S. Typhimurium T1 effector protein
SopE can activate caspase-1 in vitro.
S.TmSopE Requires Caspase-1 to Trigger Mucosal
Inflammation In Vivo in Mice
Next, we analyzed the role of caspase-1 in SopE-mediated
inflammation in vivo using the streptomycin-treated mouse
model (Barthel et al., 2003). Caspase-1/ mice and WT litter-
mates were infected for 2 days with S.TmSopE (experimental
group), S.TmSipA (positive control), S.TmD4 (negative control),
or mock-infected (0 controls). Additional controls with S.TmSopE*
are shown in Figure S2. S.TmSopE efficiently colonized the gut
lumen of all infected mice (Figure 2A). The mesenteric lymph no-
des (MLNs) of caspase-1/ mice harbored slightly increased
S.TmSopE loads (Figure 2B). This is in line with a role of cas-
pase-1 in defense against systemic infection (Lara-Tejero
et al., 2006; Raupach et al., 2006). Remarkably, S.TmSopE trig-
gered mucosal inflammation in WT, but not in the caspase-1/
mice (p = 0.001; Figures 2C and 2D). Caspase-1/mice failed to
recruit CD11b+, CD68+, F4/80+ (macrophage markers), CD11c+
(dendritic cell marker), and CD3+ (T cell marker) cells into the
infected cecal mucosa (Figure 2E). Thus, S.TmSopE requires cas-
pase-1 for eliciting inflammation.
The T1 effector protein SipA has a different molecular function
than SopE (Figure 1A), and we speculated that it might engage
different proinflammatory mechanisms in vivo. Indeed, S.TmSipA-
induced inflammation did not differ between caspase-1/ mice
and littermate controls (Figures 2C–2E). The same was observed
in control infections and in earlier work with WT S. Typhimurium
(Figure S3; Lara-Tejero et al., 2006). Thus, caspase-1/ mice
can mount mucosal inflammation and SipA and SopE induceCell Hmucosal inflammation via two different mechanisms. The
defect of caspase-1/ mice is specific for SopE-induced inflam-
mation.
The negative control strain S.TmD4 and S.TmSopE differ by the
absence/presence of the sopE gene. In line with earlier results
(Hapfelmeier et al., 2004), S.TmD4 was incapable of triggering
inflammation (Figures 2C–2E). Moreover, control experiments
with an isogenic strain harboring the catalytically inactive
sopEG168V allele verified that eliciting inflammation requires
the guanine nucleotide exchange activity of SopE (Figure S4;
Schlumberger et al., 2003).
Taken together, our data indicate that caspase-1 is required
for mucosal inflammation triggered by the S. Typhimurium T1
effector protein SopE in vivo.
Pathogen Loads in the Mucosal Tissue of WT
and Caspase-1/ Mice
Earlier work had indicated that caspase-1 may enhance Salmo-
nellacolonizationof the gut-associated lymphatic tissues (GALTs;
Monack et al., 2000). Accordingly, the failure of S.TmSopE to
trigger enterocolitis in caspase-1/ mice (Figure 2) might result
from a failure to colonize the mucosal tissue. To exclude this,
we analyzed the pathogen loads in the cecal epithelium and
lamina propria of the mice shown in Figure 2.
S.TmSopE and the control strain S.TmSipA colonized the cecal
lamina propria more efficiently than did the negative control
strain S.TmD4, verifying that both SopE and SipA can indepen-
dently facilitate mucosa invasion (Figure 3A).
Pathogen loads in the lamina propria did not differ between
caspase-1/ and WT mice. Similar observations were made
for epithelium colonization. WT mice harbored even slightly
less S.TmSopE in the epithelium than did caspase-1/ mice
(Figure 3B). We assume that this is attributable to the higher
epithelial turnover rate (higher proliferation index; Figure 3C).
This is a typical consequence of inflammation that leads to faster
shedding of infected enterocytes in the WT mice. Thus,S.TmSopE
invasion into epithelial cells does not require caspase-1.
This was confirmed in vitro using caspase-1-depleted HeLa
cells (Figure S5). Furthermore, it should be noted that
S.TmSopE-infected enterocytes (WT and caspase-1/) were still
firmly integrated into the epithelial layer and did not show nuclear
fragmentation (data not shown). This may suggest that caspase-
1 activation occurs independently of cell death in the infected
enterocytes.
In conclusion, SopE triggers caspase-1, and inflammation can
reduce the bacterial burden. Furthermore, the caspase-1/
mucosa seems to have a specific defect in the proinflammatory
signaling cascade triggered by SopE.
S.TmSopE Cannot Trigger Mucosal Inflammation
in IL-1R/ and IL-18/ Mice
Next, we have analyzed the proinflammatory signals that are
produced downstream of the SopE-induced caspase-1 activa-
tion. Active caspase-1 is known to mediate proinflammatory
signaling via cleavage of inactive prointerleukin-1b and prointer-
leukin-18 into active forms that are subsequently secreted (Black
et al., 1989; Ghayur et al., 1997; Howard et al., 1991). However,
recent work has demonstrated that caspase-1 can process
a number of additional substrates and lead to the secretion ofost & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc. 127
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Figure 2. S.TmSopE Cannot Trigger Mucosal Inflammation in Caspase-1/ Mice
Caspase-1/ mice (open circles; five per group) or WT littermates (closed circles; five to ten per group) were infected for 2 days with S.TmSopE, S.TmSipA, S.TmD4
(harboring pM973; 5 3 107 CFU by gavage) or mock infected. (A) Colonization of the cecal lumen. (B) Pathogen loads in the MLNs. (C) Cecal pathology scores;
arrows indicate the tissues depicted in (D) (HE stain). (E) Immunohistological analysis of CD11b+, CD68+, F4/80+,CD11c+, and CD3+ cells in the cecum. Quan-
titative data were from five random high-power fields from three different mice. Y origin, detection limit. Horizontal lines: median; *p < 0.05; NS, not significant; Lu.,
cecum lumen; Ed., submucosal edema; scale bar, 200 mm.128 Cell Host & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc.
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Salmonella SopE Triggers Caspase-1/IL-1 In VivoFigure 3. Pathogen Burden in the Cecal Mucosa of WT and Caspase-1/ Mice
The pathogen loads in the cecum lamina propria (A) and epithelium (B) of mice shown in Figure 2 were quantified by fluorescence microscopy. Dashed lines
indicate minimal detectable values; horizontal lines indicate median; (C) increased epithelial turnover in inflamed cecal tissue. Serial cryosections of mice shown
in Figure 2 were stained with a-Ki67 (dividing cells) and phalloidin, a-cytokeratin (enterocytes) and DAPI, or with HE (Experimental Procedures); scale bar, 100 mm.
(Right panel) The length of the Ki67-positive zone (k) was determined relative to the total epithelial crypt length (l). Bars denote average + standard deviation (nR
42 crypts); *p < 0.05; NS, not significant.a large number of proteins involved in proinflammatory signaling
and tissue repair (Keller et al., 2008). It was unclear which of
these signals mediates the SopE-induced enterocolitis.
To identify these signals, we have analyzed knockout mice
deficient in IL-1 signaling (or IL-18; see below). IL-1 receptor
knockout (IL-1R/; C57BL/6 background) mice and WT
controls were infected for 2 days with S.TmSopE (experimental
group), S.TmSipA (positive control), or S.TmD4 (negative control).
S.TmSopE efficiently colonized the gut lumen and MLN of both
groups of mice (Figures 4A and 4B). Remarkably,S.TmSopE failed
to trigger mucosal inflammation in the IL-1R/ mice (Figures 4C
and 4D). IL-1R/ mice failed to recruit CD11b+, CD68+, F4/80+
(macrophage markers), CD11c+ (dendritic cell marker), and
CD3+ (T cell marker) cells into the S.TmSopE-infected cecal
mucosa (Figure 4E). In contrast, S.TmSipA (and WT S. Typhimu-
rium; Figure S3) elicited inflammation in both IL-1R/ and WT
animals, while S.TmD4 did not elicit inflammation in either group
of mice (Figures 4C and 4E). Thus, the failure of IL-1R/ mice to
mount an inflammatory response was specific for the SopE-
induced enterocolitis.
Equivalent results were obtained with IL-18/ mice. S.TmSopE
efficiently colonized the cecal lumen and the MLN of IL-18/
mice, but it failed to trigger enterocolitis in the IL-18/ animals
(Figures 5A–5C). Thus, S.TmSopE strictly required not only cas-
pase-1 but also IL-1 receptor signaling and IL-18. In conclusion,Cell Hthese data identify IL-1 and IL-18 as key proinflammatory medi-
ators released upon SopE-mediated activation of caspase-1.
S.TmSopE Can Only Induce Enterocolitis if Caspase-1
Is Expressed in Stromal Cells
The in vivo target cells for T1 effector proteins in the intestinal
mucosa are poorly defined. Thus, the cell type in which SopE
activates caspase-1 is of considerable interest. To address
this, we have generated chimeric mice by reciprocal bone
marrow (BM) transfer (caspase-1//WT; WT/caspase-1/,
and WT/WT for control; Figures 6A–6C; reconstitution effi-
ciency >95% [Figures 6D and 6E; Experimental Procedures]).
Thereby, we could study the importance of caspase-1 signaling
in BM-derived cells (including macrophages, dendritic cells, and
T cells) or in stromal cells (including enterocytes, tissue fibro-
blasts, and vascular endothelial cells).
Eight weeks after the generation of the BM-chimeric mice, the
animals were infected for 2 days with S.TmSopE, which efficiently
colonized the gut lumen and MLN of all three groups of mice
(Figures 6A and 6B). The S.TmSopE-induced enterocolitis did
not differ significantly between the caspase-1//WT BM-
chimeras and the WT/WT controls (p R 0.05; Figure 6C).
Remarkably, S.TmSopE failed to trigger mucosal inflammation
in the WT/caspase-1/ BM chimeras (p < 0.01; Figure 6C).
These data indicated that caspase-1 was more important inost & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc. 129
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Salmonella SopE Triggers Caspase-1/IL-1 In VivoFigure 4. S.TmSopE Cannot Trigger Mucosal Inflammation in IL-1R/ Mice
(A–D) IL-1R/ mice (open circles; five per group) or WT littermates (filled circles; five to seven per group) were infected for 2 days as indicated (53 107 CFU by
gavage). (A) Colonization of the cecal lumen; (B) pathogen loads in the MLNs; (C) cecal pathology scores; arrows indicate the tissues depicted in (D); HE stain;
scale bar, 200 mm.
(E) Immunohistological analysis of CD11b+, CD68+, F4/80+,CD11c+, and CD3+ cells in the cecum; scale bar, 100 mm. Quantitative data were from five random
high-power fields from three different mice. Data for uninfected, S.TmSopE-infected and S.TmSipA-infected WT mice (obtained in parallel) was replotted from
Figure 2E. Y origin, detection limit. Horizontal lines, median; *p < 0.05; NS, not significant; Lu., cecum lumen; Ed., submucosal edema.130 Cell Host & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc.
Cell Host & Microbe
Salmonella SopE Triggers Caspase-1/IL-1 In VivoFigure 5. S.TmSopE Cannot Trigger Mucosal
Inflammation in IL-18/ Mice
IL-18/ mice (open circles) or WT littermates
(filled circles) were infected for 2 days with
S.TmSopE (5 3 107 CFU by gavage; ten mice per
group). (A) Colonization of the cecal lumen; (B)
pathogen loads in the MLNs; (C) cecal pathology
scores; Y origin, detection limit. Horizontal lines
indicate median; *p < 0.05; NS, not significant.stromal cells than in the BM-derived compartment of the gut
mucosa to allow S.TmSopE to trigger enterocolitis. Earlier
in vivo data had shown that T1 is expressed in the gut lumen
and that T1-expressing bacteria associate with enterocytes (Ac-
kermann et al., 2008). Taken together, enterocytes are the likely
in vivo target of SopE-mediated caspase-1 activation.
Western blot analysis confirmed that caspase-1 is expressed
by intestinal epithelial cells (IECs) of the normal, noninflamed
large bowel. Procaspase-1 was detected in total gut tissue. In
WT mice, IECs and the remaining gut tissue stripped of IECs
(lamina propria cells plus stromal cells like tissue fibroblasts,
endothelium, and muscle cells) expressed approximately equal
amounts of procaspase-1 (Figure 6E). Procaspase-1 expression
by IECs was confirmed by analyzing caspase-1//WT and
WT/caspase-1/ BM chimeras (Figure 6E).
The resting cecal tissue expressed only little IL-1b. However,
IL-1b levels increased within 12 hr postinfection, as determined
by western blot and RT-PCR (Figures 6F and 6G). IL-1b induction
was detected in IECs purified by density gradient centrifugation
(86% purity as determined by FACS; CD45EpCAM+) and in
FACS-sorted IECs (CD45EpCAM+ gate; 95% purity; Figure S6).
In conclusion, these data verified that caspase-1 is expressed in
resting IECs of the large bowel. IECs can also express IL-1b, at
least during a Salmonella infection. This is consistent with our
hypothesis that enterocytes represent in vivo targets of SopE-
mediated caspase-1 activation.
Ectopic SopE Expression Is Sufficient to Trigger
Caspase-1 Activation In Vitro and Dependent
on SopE-Mediated Activation of Rac-1 and Cdc42
To further elucidate the pathway employed by SopE for trig-
gering enterocolitis, we investigated the role of Rho GTPases
in SopE-induced caspase-1 activation. The Rho GTPases
Cdc42 and Rac1 are the molecular interaction partners of
SopE inside infected host cells (Friebel et al., 2001; Hardt
et al., 1998). SopE mimics eukaryotic guanine nucleotide
exchange factors and converts Rac1 and Cdc42 into their
GTP-bound active forms (Hardt et al., 1998; Schlumberger
et al., 2003), and active Rac1 was previously demonstrated to
mediate caspase-1 activation (Schotte et al., 2004). Therefore,
disruption of Rac1 activation by Clostridium difficile toxin B
(ToxB), which inactivates a large set of Rho GTPases including
Rac1, should inhibit caspase-1 activation by SopE. To test this
hypothesis, HeLa cells were pretreated with ToxB (or untreated,
positive control) and infected with S.TmSopE* or S.TmD4* (or unin-
fected, negative control). Aerolysin, a bacterial toxin activatingCell Hocaspase-1 via an unrelated mechanism, served as another posi-
tive control (Gurcel et al., 2006). Remarkably, S.TmSopE*-medi-
ated caspase-1 activation was strongly reduced by ToxB
(Figure 7A). In fact, in ToxB-treated HeLa cells, caspase-1 acti-
vation did not differ between mock-infected, S.TmD4*-infected,
or S.TmSopE*-infected cells. Thus, Rho GTPase activity is essen-
tial for S.TmSopE*-mediated caspase-1 activation.
Caspase-1 activation observed in Salmonella-infected cells
may be affected not only by SopE but also by other Salmonella
proteins such as SipB or flagellin (Franchi et al., 2006; Hersh
et al., 1999; Miao et al., 2006). Also, disruption of Rho GTPase
function interferes with efficient host cell invasion (Chen et al.,
1996). In order to avoid these caveats and to establish if SopE
alone is sufficient to activate caspase-1, HEK293T cells express-
ing procaspase-1 and pro-IL-1b (a well-established assay
system for analysis of caspase-1 activity [Schotte et al., 2004])
were cotransfected with an expression plasmid for SopE (or
the 70% homologous effector protein SopE2). Expression of
SopE resulted in proteolytic processing of procaspase-1, pro-
cessing of pro-IL-1b, and release of mature IL-1b (Figure 7B).
In contrast, transfection with an empty control vector or an
expression plasmid for the T1 effector protein SipB enhanced
neither pro-caspase-1 processing nor IL-1b maturation. Thus,
SopE is sufficient for caspase-1 activation. If overexpressed,
SopE2 can also activate caspase-1 (Figure 7B). However, if
effector protein amounts are limiting (i.e., in bacterial infections,
Figure 1C), SopE is a much more potent caspase-1 activator
than SopE2. This is attributable to differences in Rho GTPase
substrate specificity (Friebel et al., 2001) and higher bacterial
SopE expression levels (approximately 3100 SopE versus 700
SopE2 molecules per bacterial cell; I. Duss, K. Ehrbar, and
W.-D.H., unpublished data). Therefore, we conclude that SopE
is a caspase-1 activator of S. Typhimurium SL1344 in vivo.
We next confirmed that Rho GTPase activity was essential to
couple isolated SopE to caspase-1 activation. Indeed, ToxB
treatment abolished activation of caspase-1 and proteolytic
maturation of IL-1b by ectopically expressed SopE in the
HEK293T model (Figure 7C). Similarly, cotransfection of SopE
with the dominant-negative Rac1N17 abolished caspase-1 acti-
vation, maturation, and secretion of IL-1b (Figure 7D). Domi-
nant-negative Cdc42N17 partially abolished these responses.
Future work will have to address whether this is attributable to
a direct involvement of Cdc42 in the signaling cascade linking
SopE to caspase-1 or to indirect effects on Rac1 signaling. In
contrast, dominant-negative RhoAN19 did not have any effect
in our assay (Figure 7D). Moreover, transfection with the Rac1st & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc. 131
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Figure 6. S.TmSopE Enterocolitis Requires Caspase-1 in Stromal Cells
BM chimeras were infected for 2 days with S.TmSopE (5 3 107 CFU by gavage; 10–13 mice per group).
(A) Colonization of the cecal lumen.
(B) Pathogen loads in the MLNs.
(C) Cecal pathology scores; Y origin, detection limit. Horizontal lines indicate median; *p < 0.05; NS, not significant.
(D) FACS analysis of chimaerism.
(E) Western blot analysis of procaspase-1 expression in IECs, cecum tissue without IECs and whole cecum tissue (Experimental Procedures; Figure S6).
(F) Western blot analysis of IL-1b expression in cecum tissue of uninfected controls or 12 hr p.i. with WT S. Typhimurium. Positive control: LPS-treated macro-
phage lysate (left lane).
(G) IL-1b induction in cecum IECs. Cells from uninfected controls or mice 12 hr p.i. with WT S. Typhimurium were analyzed by quantitative RT-PCR (Experimental
Procedures). (Left) Whole cecum tissue; (middle) Percoll gradient purified, ‘‘isolated’’ IECs; (right) ‘‘isolated’’ IECs further purified by FACS sorting
(EpCAM+CD45 cells; Figure S6). Horizontal lines indicate median; *p < 0.05. IEC purity was determined by FACS (Figure S6).guanine nucleotide exchange factor Tiam1, constitutive active
Rac1V12, but not with catalytically inactive SopEG168V, mediated
caspase-1 activation (Figure S7). These results establish that
SopE alone is sufficient for inducing caspase-1 activation
in vitro and that SopE subverts caspase-1 signaling by activating
Rho GTPases, in particular Rac1.
DISCUSSION
We have studied how theS.Typhimurium T1 effector proteinSopE
elicits mucosal inflammation. Previous work has established the
molecular function of SopE in the context of epithelial invasion.132 Cell Host & Microbe 6, 125–136, August 20, 2009 ª2009 ElseviHowever, it has remained unclear how SopE induces gut inflam-
mation in vivo. Here we have found that the proinflammatory
effects of SopE require Rho GTPases and caspase-1. In vitro
experiments show that SopE was required and sufficient to induce
caspase-1 activation and the subsequent release of mature IL-1b,
a potent proinflammatory cytokine. Knockout mice and BM
chimeras demonstrated that SopE-induced mucosal inflamma-
tion strictly required both caspase-1 activity in stromal cells
(presumably enterocytes) and the release of the caspase-1-
dependent cytokines IL-1 and IL-18 in vivo. These data demon-
strate how the T1 effector protein SopE allows S. Typhimurium
to subvert caspase-1 to trigger mucosal inflammation in vivo.er Inc.
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Salmonella SopE Triggers Caspase-1/IL-1 In VivoFigure 7. SopE Is Sufficient for TriggeringCaspase-1 Activation, and
Rho GTPase Activation Is a Key Part of this Signaling Cascade
(A) ToxB inhibits caspase-1 activation by S.TmSopE*. HeLa cells were pre-
treated with ToxB (20 ng/ml; 2 hr; open bars) and infected (moi = 125; 30
min) or treated with aerolysin (17 ng/ml for 90 min; 37C [different caspase-1
activation mechanism; Gurcel et al., 2006]) as indicated. Caspase-1 activation
was analyzed by FLICA staining.
(B) SopE activates caspase-1. HEK293T cells were cotransfected with plas-
mids for procaspase-1, proIL-1b, and SipB, SopE, or SopE2 plasmids.
Twenty-four hours later, caspase-1 activation was analyzed by western blot
and IL-1bmaturation by western blot and bioassay (Experimental Procedures).
(C) ToxB abolishes caspase-1 activation by SopE. HEK293T cells were co-
transfected with plasmids for procaspase-1, proIL-1b, and SopE (ctr., empty
vector). ToxB (27 ng/ml; right lane) was added 3 hr after transfection. Cas-
pase-1 activation and IL-1b maturation were analyzed as in (B).
(D) Rac1N17 abolishes caspase-1 activation by SopE. HEK293T cells were co-
transfected with plasmids for procaspase-1, proIL-1b, SopE, and plasmids for
Rac1N17, Cdc42N17, or RhoAN19. Twenty-four hours later, caspase-1 activation
and IL-1b maturation were analyzed as in (B). Western blots are representative
of greater than or equal to two independent assays; bars denote the average;
standard deviation is indicated in assays performed greater than or equal to
three times.Cell HOur data emphasize the importance of caspase-1 activation in
non-BM-derived cells. Several lines of evidence suggest that en-
terocytes are the primary targets of SopE. Enterocytes express
procaspase-1 and make up virtually the entire luminal surface
of the intestinal mucosa. SopE (and T1) is expressed and a pre-
formed SopE-pool is stored in the bacterial cytosol when S.
Typhimurium grows extracellularly in the intestinal lumen (Acker-
mann et al., 2008; Schlumberger et al., 2005; Winnen et al.,
2008). Upon host cell contact, the T1 effector protein pool is
delivered into the host cell and the pathogen invades. SopE
and T1 expression ceases soon after invasion into most types
of host cell (Kubori and Galan, 2003; A.J.M. and W.-D.H., unpub-
lished data). This suggests that SopE is crucial at the initial inter-
action between lumenal bacteria and the first layer of host cells
encountered, but not during later stages of the infection. In prin-
ciple, the first cells encountered could be enterocytes or
dendritic cells forming trans-epithelial extensions (Niess et al.,
2005). However, SopE-mediated inflammation is abolished
in WT/caspase-1/ BM chimeric mice, suggesting that cas-
pase-1 activation in BM-derived cells (including dendritic cells)
is not necessary for inducing enterocolitis via SopE. Further,
DC depletion did not affect the SopE-dependent enterocolitis
(Songhet and W.-D.H., unpublished data). Based on this, we
conclude that enterocytes are likely the primary target of SopE
(Figure S8).
In the host cell, SopE activates Rho GTPases, which triggers
actin-mediated host cell invasion (Hardt et al., 1998). Our current
findings indicate that SopE-activated Rho GTPases also serves
as a signal to activate caspase-1 to trigger inflammation. Cas-
pase-1 activation leads to maturation and release of the proin-
flammatory cytokines IL-1 and IL-18. Our data indicate that
this may occur in those enterocytes harboring SopE (Figure S8).
However, we cannot exclude more complex scenarios. For
example, caspase-1 activation might compromise cell integrity,
and the released cellular debris might activate caspase-1 and
IL-1/-18 maturation in neighboring stromal cells. Future work
will have to address this issue in more detail.
Although our in vitro results clearly indicate that caspase-1
activation by SopE requires Rho GTPases, the signaling cascade
linking Rac1 and caspase-1 is not understood. Rho GTPases are
highly conserved among all eukaryotic organisms, and caspase-
1 is an essential converging point of proinflammatory signaling
pathways (Ishii et al., 2008). Both Rho GTPases and caspase-1
have central functions in responses to environmental stress,
also in the cells of the intestinal mucosa. Moreover, numerous
pathogens engage both Rho GTPases and caspase-1 to manip-
ulate the host (Aktories and Barbieri, 2005; Yu and Finlay, 2008).
Yersinia spp., for example, employs type III effector proteins for
blocking Rac1 and subsequent inhibition of caspase-1 signaling
(Prehna et al., 2006; Schotte et al., 2004; Shao et al., 2002). Thus,
a link between Rac1 and caspase-1 signaling might serve a
general function in mounting inflammatory immune responses,
but data describing this link are scarce. Functional interactions
between actin-remodeling proteins (Flightless-I, Aip1) and cas-
pases indicate that membrane ruffling may couple Rac1 to cas-
pase-1 activation (Li et al., 2008). Also, the Rac1 interaction
partner LIM kinase was implied in signaling toward caspase-1
(Schotte et al., 2004). Alternatively, a direct interaction between
the Rac1 effector ‘‘p21 activated kinase 1’’ and caspase-1 hasost & Microbe 6, 125–136, August 20, 2009 ª2009 Elsevier Inc. 133
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mediated pore formation and ion-flux-mediated caspase-1 acti-
vation might be involved (Fink and Cookson, 2006; Viboud and
Bliska, 2001). Analysis of links between Rac1 and caspase-1
will be important for future research and may have general impli-
cations for understanding pathogen-host interactions.
In macrophages, additional S. Typhimurium virulence factors
(besides SopE) can induce caspase-1 activation. The T1 effector
protein SipB may bind and activate caspase-1 (Hersh et al.,
1999). Flagellin can activate caspase-1 via flagellin-PRR interac-
tions within the host cell cytosol (Franchi et al., 2006; Miao et al.,
2006). Accordingly, S.TmD4* (lacks SopE; expresses WT T1,
SipB and flagellin levels; data not shown) induced residual cas-
pase-1 activation in macrophages (but not HeLa cells). Further-
more, this residual level of caspase-1 activation was not inhibited
by ToxB (data not shown). Thus, SipB- or flagellin-mediated cas-
pase-1 activation may have an important function when T1- and
flagellin-expressing Salmonella spp. make direct contact with
naive phagocytes (e.g., in rare cases of parenteral infection,
such as lab accidents). However, during the gut infection, these
caspase-1 activation mechanisms do not seem to contribute
significantly to mucosal inflammation, as S.TmD4 did not induce
enterocolitis. Instead, SopE was required for activating caspase-
1, releasing IL-1 and IL-18 signals, and for inducing inflammation
in the host’s gut.
Clearly, besides the SopE-induced Rac1/caspase-1/IL-1/IL-
18 cascade described here, the intestinal S. Typhimurium
infection must involve additional proinflammatory signaling
cascades. WT S. Typhimurium SL1344, which expresses SipA
and SopE, can trigger mucosal inflammation in caspase-1/
mice (Lara-Tejero et al., 2006; Figure S3). We found that SipA
allows triggering enterocolitis in caspase-1/ and in IL-1R/
knockout animals (Figures 2 and 4). This suggests that SipA
engages a different proinflammatory signaling cascade than
SopE. Most likely, in WT S. Typhimurium infections of cas-
pase-1/ mice, this signaling cascade masks the defective
SopE-mediated caspase-1 activation. Elucidation of the SipA-
induced, proinflammatory signaling cascade will be an inter-
esting topic for future research.
In conclusion, we found that Rho GTPase activation by the S.
Typhimurium effector protein SopE has (at least) two important
consequences. Besides its well-known role in Salmonella host
cell invasion, we have found that Rho GTPase activation by
SopE can induce caspase-1-mediated maturation and release
of IL-1 and IL-18. This latter mechanism may explain how
SopE elicits gut inflammation in vivo.
EXPERIMENTAL PROCEDURES
Bacteria and Plasmids
All S. Typhimurium strains are isogenic derivatives of SL1344 (Supplemental
Data, Table S1). WT, wt SL1344; T1, invG; T2, sseD::aph; T1T2, invG sse-
D::aphT; S.TmSipA, sopE sopB sopE2 sseD::aphT; S.TmSopE, sipA sopB sopE2
sseD::aphT; S.TmD4, sipA sopE sopB sopE2 sseD::aphT; S.TmSipA*, sopE
sopB sopE2; S.TmSopE*, sipA sopB sopE2; S.TmSopB*, sipA sopE sopE2;
S.TmSopE2*, sipAsopEsopB; and S.TmD4, and sipA sopE sopB sopE2.
Strains were grown at 37C in LB (0.3 M NaCl) overnight and subcultivated for
4 hrasdescribed (Hapfelmeieretal., 2004).pM973doesnot compromiseSalmo-
nella virulence (Figure S9) and, upon tissue invasion, drives GFP from a T2
promoter (Hapfelmeier et al., 2005). Plasmids for RhoAN19, Rac1N17, Cdc42N17,134 Cell Host & Microbe 6, 125–136, August 20, 2009 ª2009 Elseviepro-IL-1b, and caspase-1 have been described (Schotte et al., 2004). SopE,
SopE2, andSipBwere generated by PCR and cloned in-frame with anN-terminal
peptide E tag epitope (GAPVPYPDPLEPR) into pCAGGS-E tag.
Mice
All mice were bred and kept specified pathogen free in individually ventilated
cages (RCHCI, ETH, Zu¨rich). C57BL/6 mice originated from Charles River
(Sulzfeld, Germany). Caspase-1/ mice (B6;129S2-Casp1tm1Sesh) (Li et al.,
1995) were >99% pure C57BL/6 (SNP typing). Caspase-1+/ 3 caspase-1+/
offspring was used for experiments. IL-1R/ mice (B6;129S-Il1r1tm1Roml)
(Labow et al., 1997) crossed with C57BL/6 yielded IL-1R+/ controls. Ly5.1
(B6.SJL-Ptprca Pepcb) and IL-18/ (B6.129P2-Il18tm1Aki) mice (Takeda et al.,
1998) were rederived by embryo transfer. Genotypes (including Nramp1/)
were verified by PCR and sequencing.
For BM chimeras, recipients (g irradiated; 950 rad) received 3–6 3 107
donor-BM cells (i.v.). Chimerism was controlled by FACS on splenic, MLN,
and lamina propria leukocytes that were isolated and analyzed as described
(Hapfelmeier et al., 2008).
Streptomycin pretreated mice (20 mg/animal) were infected by gavage (53
107 CFU; Barthel et al., 2003; Hapfelmeier et al., 2008). Live bacterial loads
(colony forming units, cfu) in MLN, spleen, liver, and cecal content were deter-
mined by plating (Hapfelmeier et al., 2008). Experiments were approved
(license 201/2007 Kantonales Veterina¨ramt Zu¨rich) and performed as legally
required.
Histology
HE-stained cecum cryosections were scored as described, evaluating submu-
cosal edema, PMN infiltration, goblet cells, and epithelial damage yielding
a total score of 0–13 points (Barthel et al., 2003).
Immunostaining was performed as described (Hapfelmeier et al., 2008) by
using rat a-CD68 (clone FA-11), rat-a-F4/80 (HB-198), rat a-CD11b (M1/70),
a-CD3 (KTS), armenian hamster a-CD11c mAb N418 (HB-224), goat a-rat Ig,
goat a-armenian hamster Ig, HRP-coupled donkey a-goat Ig, amino-ethylcar-
bazol, and haemalum.
Flow Cytometry
MLN and spleen cells were analyzed as described (Hapfelmeier et al., 2008).
IEC, the gut tissue w/o peyer’s patch was washed, incubated in PBS 3 mM
EDTA for 50 min, 24C, and the cell suspension was purified by Percoll
gradient centrifugation (20% on 50% Percoll; PBS, 5 mM EDTA; 30 min,
650 g, 24C), IECs were harvested from the 20% to 50% interphase and
kept in PBS (5 mM EDTA, 1% FCS). Staining was done with APC labeled a-
CD326 (EpCAM, clone G8.8), FITC-labeled a-CD45 (clone 30-F11), APC-
labeled a-CD45.1 (clone A20), FITC-labeled a-CD45.2 (clone 104), PE-labeled
a-CD45.1 (A. Oxenius), PE-labeled a-CD11b (clone M1/70), and FITC-labeled
a-CD45 (clone 30-F11); FACS analysis with a FACSCalibur four-color cytom-
eter; sorting with a FACSAria Cell-Sorter; and data analysis with FlowJo soft-
ware (Tree Star, Inc.).
Quantitative RT-PCR
IL-1b and GAPDH mRNA levels were quantified using QIAGEN isolation kits,
M-MLV reverse Transcriptase RNase H Minus, the SensiMix Plus SYBR Green
kit (Promega), and primers as described in the Supplemental Data.
Immunofluorescence Microscopy
S. Typhimurium (pM973) in lamina propria and epithelium were enumerated by
microscopy as described using cryosections stained with a-CD54, A647-phal-
loidin, and DAPI (Hapfelmeier et al., 2005). Ki67 and cytokeratin were stained
with rabbit a-Ki67 (AbCam) or rabbit a-cytokeratin (Biomedical Technologies),
FITC-conjugated goat a-rabbit, and DAPI or A647-conjugated phalloidin
(Fluoprobes). Images were recorded with a Zeiss Axiovert 200 microscope
and an Ultraview confocal head (PerkinElmer). Crypt lengths and cell division
zones were measured by using Volocity software (Version 5.0.3., Improvision).
Statistical Analysis
Statistical analysis was performed using the exact Mann-Whitney U Test
(SPSS Version 14.0). p < 0.05 (two-tailed) was considered as statistically
significant as described (Barthel et al., 2003).r Inc.
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HeLa cells (CNX clone) were cultured in DMEM (4.5 mg/l glucose, 1% Gluta-
Max, 10% FCS), RAW264.7 cells in RPMI (10% FCS, 1% GlutaMax), and
HEK293T cells in DMEM (10% FCS, 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin sulfate, 1 mM Na-pyruvate, 23 105 M b-mercaptoe-
thanol). HEK293T cells were transiently transfected for 24 hr before adding
lysis (50 mM HEPES [pH 7.6], 200 mM NaCl, 0.1% Nonidet P-40, 5 mM
EDTA) or Laemmli buffer. Supernatant proteins were precipitated with
trichloroacetic acid.
Caspase-1 Activity Assay
Cells (1–2 3 105 per well) were seeded in 12-well plates. ToxB (20 ng/ml) was
added 2 hr prior to infection, as indicated. RAW264.7 cells were prestimulated
with 1 mg/ml purified E. coli LPS (List Biological Laboratories). Cells were in-
fected for 30 min (37C, 5% CO2; moi [HeLa] = 125; moi [RAW264.7] = 50).
Then medium (400 ug/ml gentamycin) was added and cells were stained
with FAM-YVAD-FMK (Immunochemistry Technologies; 50 min, 37C, 5%
CO2). PI (1.25 mg/ml) was added to RAW264.7 cells during the last 5 min of
incubation. In HeLa cells, there was no strict correlation between FLICA and
PI staining, and PI data were not reported. After detachment, cells were
washed, and FLICA (or PI)-positive cells were enumerated by flow cytometry.
Assays for Caspase-1 Activation and IL-1 Processing
Western blots were performed with polyclonal rabbit-a-caspase-1 (P. Vande-
nabeele), goat-a-IL-1b (R&D Systems), a-Hsp90 (Abcam), donkey-a-rabbit-
(GE Healthcare) or donkey-a-goat- (Santa Cruz Biotechnology) peroxidase
conjugates, and ECL kits. For E-tagged proteins, we used HRP-coupled a-E
tag antibody (GE Healthcare). IL-1 in supernatants was quantified with a
bioassay (see the Supplemental Data).
SUPPLEMENTAL DATA
Supplemental Data include one table, nine figures, Supplemental Experi-
mental Procedures, and Supplemental References and can be found with
this article online at http://www.cell.com/cell-host-microbe/supplemental/
S1931-3128(09)00253-4.
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